Abstract
Re: Two centres’ experience with lung cancer resection in patients with advanced non-small-cell lung cancer following treatment with immune checkpoint inhibitors: safety and clinical outcomes
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have